BIONOMICS LIMITED (BNO)

Developer of innovative treatments for cancer, mutiple sclerosis, anxiety and epilepsy.

On this page you will find:

Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
BNO	0.380	-1.3%	0.380	0.385	0.390	0.390	0.375	363,439

BIONOMICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	BNO
Securities	ASX Code, Security Description ------------------------------ BNO, Ordinary Fully Paid
Official Listing Date	21 December, 1999
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.bionomics.com.au/
Registered Office Address	31 Dalgleish Street, THEBARTON, SA, AUSTRALIA, 5031
Head Office Telephone	08 8354 6100
Head Office Fax	08 8354 6199
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 5, 115 GRENFELL STREET, ADELAIDE, SA, AUSTRALIA, 5000
Share Registry Telephone	1300 787 272

Directors / Senior Management
Mr Graeme Kaufman (Chairman) Dr Deborah Rathjen (Managing Director, CEO) Dr Errol De Souza (Non Exec. Director) Dr Jonathan Lim (Non Exec. Director) Mr Trevor Tappenden (Non Exec. Director) Ms Melanie Young (CFO)

Company Secretary	Ms Melanie Young
Principal Activities	Developer of innovative treatments for cancer, mutiple sclerosis, anxiety and epilepsy.

BIONOMICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
16/05/2013		CTX AND BIONOMICS' PROGRAM REACHES KEY MILESTONE	3	PDF
07/05/2013		Change of Director's Interest Notice	2	PDF
06/05/2013		Bionomics NOW May 2013 Newsletter	4	PDF
02/05/2013		Appendix 3B	12	PDF
30/04/2013		Appendix 4C - quarterly	3	PDF
29/04/2013		Update on BNC101 Presented at Leading US Antibody Conference	2	PDF
23/04/2013		Manufacture of BNC101 commences at Lonza	2	PDF
16/04/2013		Rights Issue - Despatch of Holding Statements	1	PDF
15/04/2013		Change of Director's Interest Notice	2	PDF
15/04/2013		Change of Director's Interest Notice	2	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
17 May 2013	0.385	-4.94%	0.410	0.370	210,558
16 May 2013	0.405	0%	0.435	0.390	555,028
15 May 2013	0.405	3.85%	0.410	0.380	198,229
14 May 2013	0.390	0%	0.390	0.385	45,164
13 May 2013	0.390	2.63%	0.390	0.380	34,685

* Volume of shares shown represents only those shares traded on ASX.

BIONOMICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BNO. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BNO

Warrants & Structured Products

No warrants & Structured Products are available over the security BNO

ASX CFDs

No Contracts For Differences are available over the security BNO

MyASX: Login | Sign up